Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 3/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.53 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.48 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.47 |
| ▸ | NQO2 | P16083 | 1/20 | 0.46 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.45 |
| ▸ | CA1 | P00915 | 1/20 | 0.44 |
| ▸ | CA2 | P00918 | 1/20 | 0.44 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.44 |
| ▸ | ADAM17 | P78536 | 1/20 | 0.44 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.44 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.44 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.44 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.44 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.44 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.44 |
| ▸ | HDAC5 | Q9UQL6 | 1/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.44 |
| ▸ | AHR | P35869 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2117754 | 1.00 | LMNA (0.53) | LMNAALDH1A1CYP1A2PTGS1KMT2A | |
| SCHEMBL2165990 | 1.00 | LMNA (0.53) | LMNAALDH1A1CYP1A2PTGS1KMT2A | |
| Hydrochloric Acid SCHEMBL28409325 | 0.98 | LMNA (0.51) | LMNAALDH1A1CYP1A2PTGS1KMT2A | |
| SCHEMBL2910604 | 0.90 | LMNA (0.46) | LMNAALDH1A1CYP1A2PTGS1KMT2A | |
| SCHEMBL2910600 | 0.90 | LMNA (0.46) | LMNAALDH1A1CYP1A2PTGS1KMT2A | |
| SCHEMBL13798820 | 0.80 | TRPV1 (0.61) | LMNAALDH1A1PTGS1KMT2AHDAC3 | |
| SCHEMBL4275683 | 0.80 | KMT2A (0.64) | ALDH1A1KMT2ASMN1; SMN2KDM4EGAA | |
| SCHEMBL4275687 | 0.80 | KMT2A (0.64) | ALDH1A1KMT2ASMN1; SMN2KDM4EGAA | |
| SCHEMBL5668373 | 0.80 | KMT2A (0.64) | ALDH1A1KMT2ASMN1; SMN2KDM4EGAA | |
| SCHEMBL27198359 | 0.80 | KMT2A (0.64) | ALDH1A1KMT2ASMN1; SMN2KDM4EGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 63 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-RE47078-E1 | Polymorphic forms of N-[4-(trifluoromethyl)benzyl]-4-methoxybutyramide | LABORATORIO FARMACEUTICO C.T. S.R.L. (IT) | 2018-10-09 | — | — | US | claimed |
| US-8742172-B2 | Polymorphic forms of N-[4-(trifluoromethyl)benzyl]-4-methoxybutyramide | LABORATORIO FARMACEUTICO C.T. S.R.L. (IT) | 2014-06-03 | — | — | US | claimed |
| US-20250109095-A1 | METHOD FOR PREPARING OXIME DERIVATIVE | SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION (KR) | 2025-04-03 | — | — | US | disclosed |
| CN-114835660-B | Preparation method of oxime ether | 浙江理工大学 | 2024-03-22 | — | — | CN | disclosed |
| CN-115246795-B | Isoxazoline compound containing ether structure at 4-phenyl para-position, preparation method thereof and application thereof as insecticidal and bactericidal agent | 瑞普（天津）生物药业有限公司 | 2024-01-02 | — | — | CN | disclosed |
| CN-114957123-B | 3- (difluoromethyl) -pyrazole-4-carboxylic ester derivative and preparation method and application thereof | 浙江工业大学 | 2023-11-28 | — | — | CN | disclosed |
| CN-114957124-B | 3- (trifluoromethyl) -pyrazole-4-carboxylic ester derivative and preparation method and application thereof | 浙江工业大学 | 2023-11-07 | — | — | CN | disclosed |
| WO-2023101319-A1 | METHOD FOR PREPARING OXIME DERIVATIVE | 서울대학교산학협력단 | 2023-06-08 | — | — | WO | disclosed |
| CN-110845486-B | Triazole alcohol derivative and preparation method and application thereof | 中国人民解放军第二军医大学 | 2023-03-21 | — | — | CN | disclosed |
| CN-115246795-A | Isoxazoline compound with 4-phenyl para-position containing ether structure, preparation thereof and application thereof as insecticide and bactericide | 瑞普（天津）生物药业有限公司 | 2022-10-28 | — | — | CN | disclosed |
| CN-114957123-A | 3- (difluoromethyl) -pyrazole-4-carboxylic ester derivative and preparation method and application thereof | 浙江工业大学 | 2022-08-30 | — | — | CN | disclosed |
| EP-1426371-A1 | TETRAZOYL OXIME DERIVATIVE AND AGRICULTURAL CHEMICAL CONTAINING THE SAME AS ACTIVE INGREDIENT | DAINIPPON INK AND CHEMICALS, INC. (JP) | 2004-06-09 | — | — | EP | disclosed |
| US-20030225158-A1 | Compounds that modulate PPAR activity and methods for their preparation | WARNER-LAMBERT COMPANY | 2003-12-04 | — | — | US | disclosed |
| US-20030195226-A1 | (Oxime)carbamoyl fatty acid amide hydrolase inhibitors | SIT SING-YUEN (US) | 2003-10-16 | — | — | US | disclosed |
| US-6376712-B2 | REDUCTION OF THE CORRESPONDING OXIME COMPOUND | CENTRAL GLASS COMPANY, LIMITED (JP) | 2002-04-23 | — | — | US | disclosed |
| US-20020013500-A1 | Process for producing trifluoromethylbenzylamines | CENTRAL GLASS COMPANY, LIMITED (JP) | 2002-01-31 | — | — | US | disclosed |
| US-6331649-B1 | REDUCING AN OXIME BY CATALYTIC HYDROGENTATION IN SOLVENT CONTAINING AN ACID | CENTRAL GLASS COMPANY, LIMITED (JP) | 2001-12-18 | — | — | US | disclosed |
| JP-2000273069-A | PRODUCTION OF TRIFLUOROMETHYLBENZYLAMINE | CENTRAL GLASS CO LTD | 2000-10-03 | — | — | JP | disclosed |
| US-4203994-A | Fungicidal 3-phenyl-5-(substituted methyl)isoxazoles | ELI LILLY AND COMPANY (US) | 1980-05-20 | — | — | US | disclosed |
| US-4109002-A | FOR PLANT FOLIAGE | ELI LILLY AND COMPANY (US) | 1978-08-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020013500-A1 | Process for producing trifluoromethylbenzylamines | MAOB, CYP2F1, AGL | LMNA 4189/4885ALDH1A1 622/4885CYP1A2 25/4885 |
| US-20030225158-A1 | Compounds that modulate PPAR activity and methods for their preparation | GPR119, PPARA, PPARG | LMNA 1929/4885ALDH1A1 2456/4885CYP1A2 4202/4885 |
| US-20030195226-A1 | (Oxime)carbamoyl fatty acid amide hydrolase inhibitors | FAAH, FAAH2, NCEH1 | LMNA 4276/4885ALDH1A1 394/4885CYP1A2 420/4885 |
| US-20250109095-A1 | METHOD FOR PREPARING OXIME DERIVATIVE | NOS2, NOS1, NOS3 | LMNA 2671/4885ALDH1A1 1430/4885CYP1A2 133/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.